Table 1: Patient characteristics.

Cat immunotherapy
Other immunotherapy
value

Gender, (%)
 Male14 (40%)17 (49%)
 Female21 (60%)18 (51%)0.47
Age (years)
 Mean (SD)49.3 (14.7)55 (13.6)0.11
 Range29–8628–89
Baseline FEV1 (%)
 Mean (SD)84.4 (21.8)86.6 (17.9)0.66
 Range38–11743–127
History of allergic rhinitis34 (97%)35 (100%)0.31
Mean duration immunotherapy (years) (SD)5.2 (1.9)5.5 (2.5)0.36
Inhaled corticosteroids , (%) 26 (74%) 23 (66%)0.43
Treatment antigens , (%)
 Dog10 (29%)9 (26%)0.79
  Pollen 16 (46%)25 (71%)0.02
 Mold3 (9%)15 (43%)0.001
 Dust/mite20 (57%)33 (94%)0.001

Allergic asthmatic patients on cat immunotherapy or traditional immunotherapy.
Comparisons between groups were made using the test and test where appropriate.